Papers
31
Total Citations
625
H-Index
14
About
Andrew A. Wagner is a leading urologic surgeon and researcher whose work has fundamentally advanced the field of robotic surgery for urologic cancers. His primary research focuses on optimizing surgical techniques and outcomes for bladder and kidney cancers, particularly through robot-assisted radical cystectomy and partial nephrectomy. Wagner is a key figure in the International Robotic Cystectomy Consortium (IRCC), where his landmark studies have compared intracorporeal versus extracorporeal urinary diversion (89 citations) and analyzed early oncologic failure and recurrence patterns after robotic cystectomy. His work has demonstrated that neoadjuvant chemotherapy does not increase perioperative morbidity, supporting its broader use. In kidney cancer, he has pioneered the early unclamping technique during robot-assisted partial nephrectomy to reduce warm ischemia time and has conducted cost analyses comparing robotic, laparoscopic, and open approaches (59 citations). Wagner has also explored innovative treatments like robotic radiosurgery for inoperable renal cell carcinoma. With multiple highly cited publications and leadership in multi-institutional collaborations, his contributions have shaped modern, minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2Comparing Costs of Robotic, Laparoscopic, and Open Partial Nephrectomy59 citations · 2012
- 3
- 4
- 5
- 6Robot-Assisted Partial Nephrectomy: Early Unclamping Technique41 citations · 2011
- 7
- 8
- 9
- 10